Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.
Saved in:
| Title: | Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways. |
|---|---|
| Authors: | Kengo Shimazu1,2,3, Yuji Tada1, Takao Morinaga2, Masato Shingyoji4, Ikuo Sekine5, Hideaki Shimada6, Kenzo Hiroshima7, Takao Namiki3, Koichiro Tatsumi1, Masatoshi Tagawa2,8 mtagawa@chiba-cc.jp, Shimazu, Kengo9,10,11 (AUTHOR), Tada, Yuji9 (AUTHOR), Morinaga, Takao10 (AUTHOR), Shingyoji, Masato12 (AUTHOR), Sekine, Ikuo13 (AUTHOR), Shimada, Hideaki14 (AUTHOR), Hiroshima, Kenzo15 (AUTHOR), Namiki, Takao11 (AUTHOR), Tatsumi, Koichiro9 (AUTHOR), Tagawa, Masatoshi10,16 (AUTHOR) |
| Source: | BMC Cancer. 5/2/2017, Vol. 17, p1-14. 14p. 1 Black and White Photograph, 1 Chart, 4 Graphs. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 122851747 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kengo+Shimazu%22">Kengo Shimazu</searchLink><relatesTo>1,2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Yuji+Tada%22">Yuji Tada</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Takao+Morinaga%22">Takao Morinaga</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Masato+Shingyoji%22">Masato Shingyoji</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Ikuo+Sekine%22">Ikuo Sekine</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Hideaki+Shimada%22">Hideaki Shimada</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Kenzo+Hiroshima%22">Kenzo Hiroshima</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Takao+Namiki%22">Takao Namiki</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Koichiro+Tatsumi%22">Koichiro Tatsumi</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Masatoshi+Tagawa%22">Masatoshi Tagawa</searchLink><relatesTo>2,8</relatesTo><i> mtagawa@chiba-cc.jp</i><br /><searchLink fieldCode="AR" term="%22Shimazu%2C+Kengo%22">Shimazu, Kengo</searchLink><relatesTo>9,10,11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tada%2C+Yuji%22">Tada, Yuji</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morinaga%2C+Takao%22">Morinaga, Takao</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shingyoji%2C+Masato%22">Shingyoji, Masato</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sekine%2C+Ikuo%22">Sekine, Ikuo</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shimada%2C+Hideaki%22">Shimada, Hideaki</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hiroshima%2C+Kenzo%22">Hiroshima, Kenzo</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Namiki%2C+Takao%22">Namiki, Takao</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tatsumi%2C+Koichiro%22">Tatsumi, Koichiro</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tagawa%2C+Masatoshi%22">Tagawa, Masatoshi</searchLink><relatesTo>10,16</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 5/2/2017, Vol. 17, p1-14. 14p. 1 Black and White Photograph, 1 Chart, 4 Graphs. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=122851747 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-017-3300-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1 Titles: – TitleFull: Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kengo Shimazu – PersonEntity: Name: NameFull: Yuji Tada – PersonEntity: Name: NameFull: Takao Morinaga – PersonEntity: Name: NameFull: Masato Shingyoji – PersonEntity: Name: NameFull: Ikuo Sekine – PersonEntity: Name: NameFull: Hideaki Shimada – PersonEntity: Name: NameFull: Kenzo Hiroshima – PersonEntity: Name: NameFull: Takao Namiki – PersonEntity: Name: NameFull: Koichiro Tatsumi – PersonEntity: Name: NameFull: Masatoshi Tagawa – PersonEntity: Name: NameFull: Shimazu, Kengo – PersonEntity: Name: NameFull: Tada, Yuji – PersonEntity: Name: NameFull: Morinaga, Takao – PersonEntity: Name: NameFull: Shingyoji, Masato – PersonEntity: Name: NameFull: Sekine, Ikuo – PersonEntity: Name: NameFull: Shimada, Hideaki – PersonEntity: Name: NameFull: Hiroshima, Kenzo – PersonEntity: Name: NameFull: Namiki, Takao – PersonEntity: Name: NameFull: Tatsumi, Koichiro – PersonEntity: Name: NameFull: Tagawa, Masatoshi IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: 5/2/2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 17 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |
